Nicotinamide adenine dinucleotide; coenzyme studied for redox, sirtuin, and cellular-energy research.
What it is
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a central redox coenzyme in cellular energy metabolism. Research catalogs study NAD+ availability in relation to sirtuins, PARPs, and mitochondrial function.
Also known as
Nicotinamide adenine dinucleotide · Coenzyme NAD
Overview
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a central redox coenzyme in cellular energy metabolism. Research catalogs study NAD+ availability in relation to sirtuins, PARPs, and mitochondrial function.
It is supplied as a research reagent for redox and aging-biology work, not as a clinical infusion protocol. Left Turn Adventures supplies this compound for laboratory and research use only.
Proven benefits
Note: Preclinical / literature endpoints for labs not established human treatment benefits. Not a protocol.
Cellular redox and NAD+/NADH ratio endpoints
• Sirtuin and PARP-pathway research markers
• Mitochondrial energy-metabolism readouts
• Aging and cellular-stress models tied to NAD pools
• Comparative precursor studies (NMN, NR) versus direct NAD+
Results timeline
Note: Illustrative research-observation windows — not a clinical schedule. No dosing.
Week 1–2: Early mitochondrial and energy-metabolism readouts; compound accumulating in model systems.
Week 3–4: Clearer redox, endurance, or cellular-energy markers in short preclinical windows.
Month 2–3: More pronounced metabolic and cytoprotection endpoints in extended designs.
Month 3–6: Sustained mitochondrial and aging-adjacent observations where studied longer.
The catalog, not a clinic
For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.